BioMed Realty toasts 20th anniversary with $22bn+ portfolio as Real Estate powerhouse

Founded in 2004, BioMed Realty was one of the first real estate companies to cater to the life science industry, delivering Class A, mission-critical lab space to the world’s greatest innovators.

Since Blackstone Real Estate acquired BioMed Realty in 2016, the company has grown significantly and is now the largest private operator of life science real estate with a portfolio valued at more than $22 billion.

The business operates 16 million square feet of life science infrastructure within core innovation hubs in the US and UK, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder in the States and Cambridge UK.

BioMed Realty entered the UK life science real estate market in 2012 via acquisition of the 120-acre Granta Park campus in Cambridge.

BioMed Realty’s Chief Executive Officer Tim Schoen said: “As we enter our third decade, our core mission has remained the same: to provide life science and technology companies with world-class innovation space, so they can continue to advance human health.

“Our team’s commitment to providing mission-critical infrastructure has helped our company build many valuable tenant and community relationships. We look forward to the next 20 years of paving the way for human discovery as we continue to accelerate innovation.”